Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-80,614
Closed -$9.16M 207
2024
Q1
$9.16M Sell
80,614
-6,083
-7% -$697K 2.65% 9
2023
Q4
$9.54M Hold
86,697
2.98% 6
2023
Q3
$8.4M Sell
86,697
-9
-0% -$945 2.86% 8
2023
Q2
$9.45M Hold
86,706
3.24% 7
2023
Q1
$9.04M Sell
86,706
-1,836
-2% -$194K 3.11% 8
2022
Q4
$9.72M Buy
88,542
+1,836
+2% +$190K 3.72% 6
2022
Q3
$8.39M Sell
86,706
-1,883
-2% -$201K 3.86% 5
2022
Q2
$94.2K Buy
88,589
+41
+0% +$4.66K 26.32% 2
2022
Q1
$10.9M Hold
88,548
5.21% 3
2021
Q4
$12.5M Buy
+88,548
New +$11.3M 5.12% 3

Other funds holding ABT

Apeiron RIA's ABT Position: Q2 2024 in Review

Apeiron RIA sold out of Abbott (ABT) in Q2 2024, closing a stake of 80,614 shares — an estimated $9.16M sold.

Apeiron RIA first reported a position in ABT in Q4 2021 and held it in 10 quarters. The position peaked at $12.5M in Q4 2021. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Apeiron RIA reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Apeiron RIA sold 80,614 Abbott shares in Q2 2024, an estimated $9.16M.
  • Apeiron RIA first reported a position in Abbott in Q4 2021 and held it in 10 quarters.
  • Apeiron RIA's Abbott position peaked at $12.5M in Q4 2021.
  • 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Apeiron RIA's 13F filing for Q2 2024, filed 16 Jul 2024.